Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115648) titled 'Application of bupivacaine liposome for fascia iliaca compartment block in total hip arthroplasty : A randomized controlled trial' on Dec. 29, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The Second Hospital of Dalian Medical University
Condition:
Total hip replacement surgery
Intervention:
Liposome bupivacaine group (Group A):10ml (133mg) of bupivacaine lipid solution plus 20ml of 0.9% normal saline, totaling 30ml.
Bupivacaine group (Group B): 0.25% bupivacaine, 30 ml.
Recruitment Status: Not Recruiting
Phase: New Treatment Measure Clinical Study
Date of First Enroll...